Effects of <i>IGF2BP2, KCNQ1</i> and <i>GCKR</i> Polymorphisms on Clinical Outcome in Metastatic Gastric Cancer Treated with EOF Regimen

Abstract

Our results suggest IGF2BP2 and KCNQ1 polymorphisms might be independent predictors of chemotherapeutic response, while GCKR polymorphisms might be independent predictors of survival in MGC patients treated with first-line EOF chemotherapy. Original submitted 30 June 2014; revision submitted 15 April 2015.